The intestinal absorption of calcium (Ca) from Ca ascorbate (Ca-AsA) was investigated in normal rats. Each animal was perorally
administered either 5 mg (low dose) or 10 mg (high dose) of Ca in 1 ml of distilled water as Ca-AsA, Ca carbonate (CaCO
3), or Ca chloride (CaCl
2), which were intrinsically labeled with
45Ca using
45CaCl
2. The amount of radioactivity in plasma was measured periodically up to 34 h after dosing, and pharmacokinetic parameters
were calculated from the radioactivity in plasma. The time taken to reach the maximum
45Ca level (T
max) did not differ among the three groups. The area under the plasma
45Ca level/time curve (AUC∞) value for the Ca-AsA group was significantly higher than those for the CaCO
3 and the CaCl
2 groups. The radioactivity at T
max (C
max) for the Ca-AsA group was significantly higher than those for the CaCO
3 and the CaCl
2 groups for the low dose, and comparable with or significantly higher than those for the CaCl
2 and CaCO
3 groups for the high dose. Similar results were observed for whole-body
45Ca retention. Radioactivity in the femur 34 h after dosing was the highest in the Ca-AsA group and the lowest in the CaCO
3 group. The rank order of solubility in water, the first fluid (pH 1.2, JP-1) of JPXIII disintegration medium, acetate buffer
solution (pH 4.0), triethanolamine-malate buffer solution (pH 7.0) and ammonium chloride buffer solution (pH 10.0) at 37°C
was CaCl
2 > Ca-AsA > CaCO
3. In contrast, the rank order of the solubility in the second fluid (pH 6.8, JP-2) of JPXIII disintegration medium at 37°C
was Ca-AsA > CaCl
2 > CaCO
3. These results indicate that the absorbability of Ca from Ca-AsA is almost comparable with, or higher than, that from CaCl
2 and significantly higher than that from CaCO
3 because of its high degree of solubility in the intestine. Therefore, Ca-AsA would be useful as a Ca supplement with relatively
high absorption from intestine.
Key words: Ca ascorbate - Ca carbonate - Ca chloride - solubility in solution - absorption from intestine
Received: March 31, 1998 / Accepted: June 16, 1998